Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 240MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 300MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 320MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 350MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ioversol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ioversol, including repackagers and relabelers. The FDA regulates Ioversol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ioversol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ioversol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ioversol supplier is an individual or a company that provides Ioversol active pharmaceutical ingredient (API) or Ioversol finished formulations upon request. The Ioversol suppliers may include Ioversol API manufacturers, exporters, distributors and traders.
click here to find a list of Ioversol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ioversol DMF (Drug Master File) is a document detailing the whole manufacturing process of Ioversol active pharmaceutical ingredient (API) in detail. Different forms of Ioversol DMFs exist exist since differing nations have different regulations, such as Ioversol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ioversol DMF submitted to regulatory agencies in the US is known as a USDMF. Ioversol USDMF includes data on Ioversol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ioversol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ioversol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ioversol Drug Master File in Japan (Ioversol JDMF) empowers Ioversol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ioversol JDMF during the approval evaluation for pharmaceutical products. At the time of Ioversol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ioversol suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ioversol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ioversol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ioversol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ioversol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ioversol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ioversol suppliers with NDC on PharmaCompass.
Ioversol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ioversol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ioversol GMP manufacturer or Ioversol GMP API supplier for your needs.
A Ioversol CoA (Certificate of Analysis) is a formal document that attests to Ioversol's compliance with Ioversol specifications and serves as a tool for batch-level quality control.
Ioversol CoA mostly includes findings from lab analyses of a specific batch. For each Ioversol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ioversol may be tested according to a variety of international standards, such as European Pharmacopoeia (Ioversol EP), Ioversol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ioversol USP).
LOOKING FOR A SUPPLIER?
